Biotech

All Articles

Vaccine and Keytruda combination reliable in squamous cell cancer

.Immune checkpoint inhibitors are the superheroes of cancer cells treatment. Drugs like Bristol Myer...

Cue Biopharma queues up J&ampJ vet as CBO-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our roundup of notable leadership hirings, firings and a...

Regeneron's Opdualag competitor presents 57% response fee

.Regeneron is back along with lasting follow-up for its LAG-3 prevention and PD-1 inhibitor combinat...

AstraZeneca posts information on internal competitors to AbbVie, Pfizer ADCs

.AstraZeneca has discussed an early check out the efficiency of its own in-house antibody-drug conju...

iTeos- GSK's TIGIT superstar shows significant enhancement

.After declaring a stage 3 launch based on beneficial midstage results, iTeos as well as GSK are eve...

More collaborative FDA can easily increase rare ailment R&ampD: file

.The FDA must be much more available and collective to let loose a rise in approvals of rare health ...

Zenas, MBX, Bicara head to Nasdaq in very hot time for biotech IPOs

.It is actually an unusually active Friday for biotech IPOs, with Zenas BioPharma, MBX as well as Bi...

Atea's COVID antiviral neglects to halt hospital stays in period 3

.Atea Pharmaceuticals' antiviral has failed yet another COVID-19 trial, but the biotech still stores...

Neurocrine's bid to spare schizophrenia prospect falls short

.Neurocrine Biosciences' mental illness plan pivot has actually stopped working. The biotech was not...

Sanofi spends $110M upfront for late-stage radioligand therapy

.Sanofi has created a late access to the radioligand event, paying for 100 million euros ($ 110 thou...